RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
about
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individualsNbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and RepairAberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing geneRare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyGenetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer familiesHereditary breast cancer: ever more pieces to the polygenic puzzle.Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancerMutation analysis of the AATF gene in breast cancer families.Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapyBreast cancer susceptibility: current knowledge and implications for genetic counsellingIdentifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome.Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection.Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemiaHereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Growing recognition of the role for rare missense substitutions in breast cancer susceptibilityThe redox biology network in cancer pathophysiology and therapeuticsTargeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cellsClinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.Mutation screening of RAD51C in high-risk breast and ovarian cancer families.Gene-panel sequencing and the prediction of breast-cancer risk.Mechanisms of BRCA1 tumor suppressionAssociation of the nibrin gene (NBN) variants with breast cancer.Network-based global inference of human disease genesA novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and functionHereditary breast cancer in the Han Chinese population.Estimating cumulative risks for breast cancer for carriers of variants in uncommon genesHeterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.Molecular genetics of breast and ovarian cancer: recent advances and clinical implicationsFamilial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response functionMolecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapyHeterozygous mutations in PALB2 cause DNA replication and damage response defects.The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.Update on genetic predisposition to breast cancer.Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
P2860
Q22000758-839765ED-9E71-4255-ABAF-BB269775208CQ27657670-537DA3C7-42F1-40D9-A9C2-64324467DD85Q28242019-74B0BEDD-FCD4-4886-BF64-1DC979807410Q28652308-1D0057C8-C6AD-4E95-891B-FAD5A9B08391Q30886820-EF05C557-0660-4CCB-9187-BEB1F203415DQ33337514-384A51B7-7960-4A8E-AA8C-D23B8A0126ADQ33356511-D20F4B48-1613-4038-BED9-64945D8C4A00Q33467074-99129398-6514-4A40-A864-ADB576D5C6F6Q33520087-1F4763CF-C21E-4C37-87F0-3150B6BB9930Q33677756-9288CC8D-3D20-4CBA-BEF0-031A58AAC215Q33727876-6BE01D61-FE86-4000-95E6-E16DB3C52B08Q34161642-D0712283-EEEA-4B87-A5CF-9E5F29B09036Q34459725-0529AE88-A037-4B60-8C6A-F309CD4CBD39Q34700093-09B9950E-F20A-47B2-9BB4-CDA148ECEBE5Q34787446-5CBF3A81-9F77-43F2-9C9F-9E37005543E2Q35008025-FBF48217-D0DD-453D-8DC2-07F5044CD625Q35029638-B9953BAB-122A-41C5-BA25-2A9F986A1E02Q35070267-D4AD1B1D-64A1-440C-B16B-7C05BD074037Q35106767-223D531E-723B-4727-A508-B410113D5FFEQ35849711-2639024A-6C67-421D-872E-C586F1D76AEBQ35906993-C9924C91-1E68-4F47-9A51-61C8F1A87DA0Q35909521-6CCFF8B7-5E57-45D3-AE5F-09B12F9EA9EAQ36101775-630BE383-3038-4C6B-934C-2EE667FDCEF9Q36162179-2946839D-FED7-4C97-A0B7-94116D0E1FD9Q36175072-8B7DA050-133B-484C-8E0C-35B72365A0D8Q36219554-70F756B9-A33E-4B1B-B3A4-AD1C1A5D5D49Q36639921-4A2663A5-A108-4EB2-ABC4-95D725F7D12DQ36713985-511DC0DC-2EDE-4AC4-8EFA-62644D4C002DQ36922848-E706772B-D8F5-4769-8C76-645F8A2083A2Q36978755-A8B1F253-EB29-4D65-9C68-C07C1C50C9D0Q36990074-554B3769-FDD4-4474-B6DF-17956D1F5D95Q37128441-AB8ED15F-BB9F-402B-9F87-1226754BEE25Q37181547-37AF3DE9-F48A-43D1-BC20-3AA72B7E944AQ37217527-033BA6A1-BE50-42E9-AA47-7F6D7742817CQ37241324-F8BCE841-2AB6-4949-9642-36A2DF7E76F9Q37305285-49A253AB-09C0-4102-8961-B79E9C805A22Q37376899-A21FB047-3A31-4362-AB6B-6D89720D81FBQ37577923-A4600B3D-479F-471C-8487-D8A8FD663F0EQ37684672-AA35AF1F-9B98-420E-ABEA-31DB0F230453Q37691100-A841144F-DEF2-485D-88E1-AE715F8C1D88
P2860
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@ast
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@en
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@nl
type
label
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@ast
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@en
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@nl
prefLabel
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@ast
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@en
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@nl
P2093
P2860
P50
P356
P1433
P1476
RAD50 and NBS1 are breast canc ...... ated with genomic instability.
@en
P2093
Hannele Erkko
John Petrini
Katri Heikkinen
Katrin Rapakko
Rosa B Barkardottir
Sakari Knuutila
Sanna-Maria Karppinen
Tuija Lundán
P2860
P304
P356
10.1093/CARCIN/BGI360
P407
P577
2006-02-12T00:00:00Z